Eli Lilly ( LLY - news - people )'s bone-building osteoporosis drug Forteo, or parathyroid hormone.
FORBES: Health
Lilly also said it is close to gaining approval on Forteo.
FORBES: Magazine Article
Strattera, a nonstimulant treatment for attention deficit disorder, and osteoporosis drug Forteo have both been approved by the FDA and launched in the past few months.
FORBES: Lilly's And Schering's Blockbuster Hangovers
应用推荐
模块上移
模块下移
不移动